In a tumour milieu LCN2 is potentiated by proinflammatory cytokines Il-1β, TNF-α, and IL-17 [47] and is involved in the epithelial to mesenchymal transition (EMT) [48], [49]. This evidence concerns the gene LCN2 and neoplasm.